Blood haemoglobin is an independent predictor of B-type natriuretic peptide (BNP)

Clinical Science

Volumn 109, Issue 1, 2005, Pages 69-74

  Wold Knudsen, Cathrine ^a   Vik Mo, Harald ^b   Omland, Torbjørn ^c,d  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d AKERSHUS UNIVERSITY HOSPITAL   (Norway)

Author keywords

Anaemia; B type natriuretic peptide (BNP); Haemoglobin; Heart failure

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEMOGLOBIN;

ADULT; AGE; AGED; ANEMIA; ARTICLE; BODY MASS; CORONARY ARTERY DISEASE; CREATININE CLEARANCE; FEMALE; GENDER; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEMATOCRIT; HEMOGLOBIN DETERMINATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS;

EID: 21744450788     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20040349     Document Type: Article

References (26)

1. de Lemos, J. A., McGuire, D. K. and Drazner, M. H. (2003) B-type natriuretic peptide in cardiovascular disease. Lancet 362, 316-322
2. Ruskoaho, H. (2003) Cardiac hormones as diagnostic tools in heart failure. Endocr. Rev. 24, 341-356
3. Omland, T., Aakvaag, A. and Vik-Mo, H. (1996) Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment. Heart 76, 232-237
4. Yamamoto, K., Burnett, Jr, J. C., Jougasaki, M. et al. (1996) Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 28, 988-994
5. Maisel, A. S., Krishnaswamy, P., Nowak, R. M. et al. (2002) Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N. Engl. J. Med. 347, 161-167
6. Omland, T., Aakvaag, A., Bonarjee, V. V. et al. (1996) Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term prognosis after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation 93, 1963-1969
7. de Lemos, J. A., Morrow, D. A., Bentley, J. H. et al. (2001) The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N. Engl. J. Med. 345, 1014-1021
8. Richards, A. M., Nicholls, M. G., Espiner, E. A. et al. (2003) B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation 107, 2786-2792
9. Sabatine, M. S., Morrow, D. A., de Lemos, J. A. et al. (2002) Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation 105, 1760-1763
10. Omland, T., Richards, A. M., Wergeland, R. and Vik-Mo, H. (2005) B-type natriuretic peptide and long-term survival in patients with stable coronary artery disease. Am. J. Cardiol. 95, 24-28
11. Tsutamoto, T., Wada, A., Maeda, K. et al. (1997) Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 96, 509-516
12. Anand, I. S., Fisher, L. D., Chiang, Y. T. et al. (2003) Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation 107, 1278-1283
13. Wang, T. J., Larson, M. G., Levy, D. et al. (2004) Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N. Engl. J. Med. 350, 655-663
14. Redfield, M. M., Rodeheffer, R. J., Jacobsen, S. J., Mahoney, D. W., Bailey, K. R. and Burnett, Jr, J. C. (2002) Plasma brain natriuretic peptide concentration: impact of age and gender. J. Am. Coll. Cardiol. 40, 976-982
15. Wang, T. J., Larson, M. G., Levy, D. et al. (2002) Impact of age and sex on plasma natriuretic peptide levels in healthy adults. Am. J. Cardiol. 90, 254-258
16. McCullough, P. A., Due, P., Omland, T. et al. (2003) B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Study. Am. J. Kidney Dis. 41, 571-579
17. Wang, T. J., Larson, M. G., Levy, D. et al. (2004) Impact of obesity on plasma natriuretic peptide levels. Circulation 109, 594-600
18. Anand, I., McMurray, J. J., Whitmore, J. et al. (2004) Anaemia and its relationship to clinical outcome in heart failure. Circulation 110, 149-154
19. Horwich, T. B., Fonarow, G. C., Hamilton, M. A., MacLellan, W. R. and Borenstein, J. (2002) Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J. Am. Coll. Cardiol. 39, 178-186
20. van der Meer, P., Voors, A. A., Lipsic, E., Smilde, T. D., van Gilst, W. H. and van Veldhuisen, D. J. (2004) Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure. J. Am. Coll. Cardiol. 44, 63-67
21. Brucks, S., Little, W. C., Chao, T. et al. (2004) Relation of anaemia to diastolic heart failure and the effect of outcome. Am. J. Cardiol. 93, 1055-1057
22. Yandle, T. G., Richards, A. M., Gilbert, A., Fisher, S., Holmes, S. and Espiner, E. A. (1993) Assay of brain natriuretic peptide (BNP) in human plasma: evidence for high molecular weight BNP as a major plasma component in heart failure. J. Clin. Endocrinol. Metab. 76, 832-838
23. Kalra, P. R., Anagnostopoulos, C., Bolger, A. P., Coats, A. J. and Anker, S. D. (2002) The regulation and measurement of plasma volume in heart failure. J. Am. Coll. Cardiol. 39, 1901-1908
24. Feigenbaum, M. S., Welsch, M. A., Mitchell, M., Vincent, K., Braith, R. W. and Pepine, C. J. (2000) Contracted plasma and blood volume in chronic heart failure. J. Am. Coll. Cardiol. 35, 51-55
25. Anand, I. S., Chandrashekar, Y., Ferrari, R., Poole-Wilson, P. A. and Harris, P. C. (1993) Pathogenesis of oedema in chronic severe anaemia: studies of body water, sodium, renal function, hemodynamic variables, and plasma hormones. Heart 70, 357-362
26. Isbister, J. P. (1997) Physiology and pathophysiology of blood volume regulation. Transfus. Sci. 18, 409-423